Regulators Warn Against Recalled Semaglutide and Tirzepatide Dispensing

Posted 10 July 2026

South African health regulators have issued a joint warning to healthcare professionals regarding the continued prescription and dispensing of recalled iDEXIS Semaglutide and Tirzepatide products under the Medicines and Related Substances Act.

Read More »



The views expressed herein are those of the author and do not necessarily reflect those of Acts Online. Acts Online accepts no responsibility for the accuracy, completeness or fairness of the article, nor does the information contained herein constitute advice, legal or otherwise.